Laminate's VasQ External Scaffold Launched for Forearm AV Fistula Procedures in Germany
July 20, 2018—Laminate Medical Technologies announced the initial use of VasQ for forearm fistula procedures in Germany. VasQ is an implanted blood vessel external support device for patients requiring an arteriovenous (AV) fistula as vascular access for hemodialysis. The procedures were performed by seven surgeons at six hospitals. VasQ has received European CE Mark approval and is in use in hospitals in Europe and Israel.
According to the company, VasQ is an external scaffold placed over the fistula. This creates a geometric configuration with the artery, reducing the tension in the vein and allowing proper blood flow during dialysis while reducing vein blockage created by thickening of the vein wall.
Robert Shaverdyan, MD, Head of the Vascular Access Center, Asklepios Clinic Barmbek in Hamburg, Germany, commented in Laminate's announcement, "As one of the first worldwide users of the VasQ external scaffold for AV anastomosis for forearm fistula creation, I am very excited about the device and the possible short-, mid-, and long-term benefits it may provide to patients. Its application is very easy, and its handling adds very little time to the fistula procedure."
Dr. Shaverdyan continued, "Since it is well established that the geometrical configuration of the AV anastomosis is crucial for reducing the future risk of perianastomotic stenosis, in my personal opinion, it would be particularly advantageous to apply the VasQ device in patients with significant distance between the radial artery and forearm cephalic vein and therefore avoid the related unnecessary and sometimes inevitable kinking of the perianastomotic vein and associated stenosis. I am awaiting the first results of the forearm VasQ device."
Christos Petridis, MD, Head of the Division of Vascular Surgery at Marienkrankenhaus in Hamburg, Germany, added, “For me as a vascular access surgeon, keeping things simple is the key. Using the VasQ forearm device is as simple as the upper arm procedure, with the same smooth and familiar handling. Therefore, I am excited to see the great results of the upper arm confirmed in forearm access patients.”